Our experiments further revealed that additional silencing of METTL3 cannot further decrease the phosphorylation level of mTORC1 and glycolysis activity in Rapamycin‐treated (mTOR‐suppressed) HCC cells. The gene discussed is METTL3; the disease is hepatocellular carcinoma.